Fractyl Shares Drop Despite Positive Revita Weight Maintenance Data
Fractyl Health released six-month interim results from its REMAIN-1 trial. The study tested Revita weight maintenance after patients stopped GLP-1 drugs like Wegovy or Zepbound. Those treated with Revita regained 4.5% of
